Freeline Therapeutics Holdings plc
FRLN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $28,174 | $70,695 | $258,431 | $114,261 |
| - Cash | $47,279 | $117,662 | $229,974 | $73,702 |
| + Debt | $5,924 | $0 | $0 | $0 |
| Enterprise Value | -$13,181 | -$46,967 | $28,457 | $40,559 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1,740 | -$2,390 | -$1,928 | -$1,546 |
| % Margin | – | – | – | – |
| EBITDA | -$97,174 | -$133,137 | -$85,267 | -$51,509 |
| % Margin | – | – | – | – |
| Net Income | -$88,972 | -$140,391 | -$96,322 | -$53,909 |
| % Margin | – | – | – | – |
| EPS Diluted | -22.52 | -58.98 | -102.09 | -127.39 |
| % Growth | 61.8% | 42.2% | 19.9% | – |
| Operating Cash Flow | -$78,224 | -$107,557 | -$94,965 | -$52,322 |
| Capital Expenditures | -$7,014 | -$4,274 | -$2,514 | -$3,022 |
| Free Cash Flow | -$85,238 | -$111,831 | -$97,479 | -$55,344 |